232 related articles for article (PubMed ID: 21424693)
1. Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse.
Lynch WJ; Bond C; Breslin FJ; Johnson BA
Psychopharmacology (Berl); 2011 Sep; 217(1):3-12. PubMed ID: 21424693
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic administration of a low-dose combination of topiramate and ondansetron reduces ethanol's reinforcing effects in male alcohol preferring (P) rats.
Moore CF; Lycas MD; Bond CW; Johnson BA; Lynch WJ
Exp Clin Psychopharmacol; 2014 Feb; 22(1):35-42. PubMed ID: 24490709
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of a low dose combination of topiramate and naltrexone on ethanol reinforcement and consumption in rat models.
Moore CF; Protzuk OA; Johnson BA; Lynch WJ
Pharmacol Biochem Behav; 2014 Jan; 116():107-15. PubMed ID: 24252444
[TBL] [Abstract][Full Text] [Related]
4. Effect of topiramate treatment on ethanol consumption in rats.
Breslin FJ; Johnson BA; Lynch WJ
Psychopharmacology (Berl); 2010 Jan; 207(4):529-34. PubMed ID: 19823810
[TBL] [Abstract][Full Text] [Related]
5. Topiramate for treating alcohol dependence: a randomized controlled trial.
Johnson BA; Rosenthal N; Capece JA; Wiegand F; Mao L; Beyers K; McKay A; Ait-Daoud N; Anton RF; Ciraulo DA; Kranzler HR; Mann K; O'Malley SS; Swift RM; ;
JAMA; 2007 Oct; 298(14):1641-51. PubMed ID: 17925516
[TBL] [Abstract][Full Text] [Related]
6. Effect of repeated treatment with topiramate on voluntary alcohol intake and beta-endorphin plasma level in Warsaw alcohol high-preferring rats.
Zalewska-Kaszubska J; Bajer B; Gorska D; Andrzejczak D; Dyr W; Bieńkowski P
Psychopharmacology (Berl); 2013 Jan; 225(2):275-81. PubMed ID: 22847457
[TBL] [Abstract][Full Text] [Related]
7. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.
Johnson BA; Ait-Daoud N; Akhtar FZ; Ma JZ
Arch Gen Psychiatry; 2004 Sep; 61(9):905-12. PubMed ID: 15351769
[TBL] [Abstract][Full Text] [Related]
8. Effects of subunit selective nACh receptors on operant ethanol self-administration and relapse-like ethanol-drinking behavior.
Kuzmin A; Jerlhag E; Liljequist S; Engel J
Psychopharmacology (Berl); 2009 Mar; 203(1):99-108. PubMed ID: 18987848
[TBL] [Abstract][Full Text] [Related]
9. Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.
Johnson BA
Biochem Pharmacol; 2008 Jan; 75(1):34-56. PubMed ID: 17880925
[TBL] [Abstract][Full Text] [Related]
10. Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats.
Hargreaves GA; McGregor IS
Alcohol Clin Exp Res; 2007 Nov; 31(11):1900-7. PubMed ID: 17877781
[TBL] [Abstract][Full Text] [Related]
11. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.
Johnson BA; Ait-Daoud N; Bowden CL; DiClemente CC; Roache JD; Lawson K; Javors MA; Ma JZ
Lancet; 2003 May; 361(9370):1677-85. PubMed ID: 12767733
[TBL] [Abstract][Full Text] [Related]
12. Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence.
Ait-Daoud N; Johnson BA; Prihoda TJ; Hargita ID
Psychopharmacology (Berl); 2001 Feb; 154(1):23-7. PubMed ID: 11292002
[TBL] [Abstract][Full Text] [Related]
13. Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone.
Froehlich JC; Hausauer BJ; Rasmussen DD
Alcohol Clin Exp Res; 2013 Oct; 37(10):1763-70. PubMed ID: 23875623
[TBL] [Abstract][Full Text] [Related]
14. Effects of topiramate on ethanol and saccharin consumption and preferences in C57BL/6J mice.
Gabriel KI; Cunningham CL
Alcohol Clin Exp Res; 2005 Jan; 29(1):75-80. PubMed ID: 15654294
[TBL] [Abstract][Full Text] [Related]
15. Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study.
Miranda R; MacKillop J; Monti PM; Rohsenow DJ; Tidey J; Gwaltney C; Swift R; Ray L; McGeary J
Alcohol Clin Exp Res; 2008 Mar; 32(3):489-97. PubMed ID: 18215213
[TBL] [Abstract][Full Text] [Related]
16. Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents.
McBride WJ; Li TK
Crit Rev Neurobiol; 1998; 12(4):339-69. PubMed ID: 10348615
[TBL] [Abstract][Full Text] [Related]
17. Zonisamide decreases ethanol intake in rats and mice.
Knapp CM; Mercado M; Markley TL; Crosby S; Ciraulo DA; Kornetsky C
Pharmacol Biochem Behav; 2007 May; 87(1):65-72. PubMed ID: 17482246
[TBL] [Abstract][Full Text] [Related]
18. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.
Knapp CM; Ciraulo DA; Sarid-Segal O; Richardson MA; Devine E; Streeter CC; Oscar-Berman M; Surprise C; Colaneri L; Putnam M; Waters M; Richambault C
J Clin Psychopharmacol; 2015 Feb; 35(1):34-42. PubMed ID: 25427171
[TBL] [Abstract][Full Text] [Related]
19. Effects of 5-HT(3) receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats.
Rodd-Henricks ZA; McKinzie DL; Edmundson VE; Dagon CL; Murphy JM; McBride WJ; Lumeng L; Li TK
Alcohol; 2000 May; 21(1):73-85. PubMed ID: 10946160
[TBL] [Abstract][Full Text] [Related]
20. Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials.
Falk D; Wang XQ; Liu L; Fertig J; Mattson M; Ryan M; Johnson B; Stout R; Litten RZ
Alcohol Clin Exp Res; 2010 Dec; 34(12):2022-34. PubMed ID: 20659066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
